Psylink

Psylink is a pioneering force in biotechnology research, dedicated to advancing the frontiers of synthetic biology for the betterment of science and humanity. Focused on developing innovative targeted psychedelic agents, Psylink selectively intervenes with serotonin receptors to address some of the most challenging mental health disorders.

Utilizing cutting-edge synthetic biology and genome engineering tools, Psylink creates both well-known and novel psychedelic derivatives. These compounds are rigorously tested in preclinical and clinical research, driving progress towards the eradication of debilitating mental health conditions and improving patient outcomes.

Located at Sauletekio al. 7C, Vilnius, 10257, LT, Psylink is committed to transforming mental healthcare through groundbreaking research and development. We invite the management team at Psylink to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to the field. Information will be completed soon with the support of the company’s management.